Facilities

We dig into the story of Lonza in China, and its new HPAPI expansion in Guangzhou

Efficient, reliable scale up is a key component of mAb production. Thermo Fisher Scientific’s modularized system provides individual building blocks.

Matthew Zustiak from Thermo Fisher Scientific discusses the challenges of equipment choice for producing mAbs.

We find out how technology is enabling remote inspections in the pharma industry.

With the FDA still behind on inspections, manufacturers need to uncover their own blindspots.

Reconfigure. Redefine. Why modular cleanroom furniture is essential for a changing pharmaceutical market.

A microfluidic bioprocessing company has set up shop in central Scotland. We spoke to their CEO for an inside view.

Nominations and voting for the Power List, Company of the Year Awards, and Innovation Awards ends on Thursday 17 March

Yvonne Duckworth lays out insights into Pharma 4.0 gleaned in a recent report by CRB. VR, AR, AI: is it more than just alphabet soup?

Changes are coming to Annex 1 of the EU’s GMP. What can pharma expect?